Myocyte deficiency as a target in the treatment of cardiomyopathy☆
To access this article, please choose from the options below
☆ Supported by grants from the National Institutes of Health (RO1 HL70194, HL44578 and HL072924 (NHB, KAW), a Ruth L. Kirschstein National Research Service Award (LAS) and an NIH-NHLBI Training Grant Fellowship (5 T32 HL007188-30, COR).
PII: S1058-9813(07)00002-1
doi:10.1016/j.ppedcard.2007.05.001
© 2007 Published by Elsevier Inc.
